Living Well With Indolent Systemic Mastocytosis

Update: 2024-09-30

Description

In this episode of the Patient Power podcast Unraveling Cancer, we explore indolent systemic mastocytosis. Patient Power host Ruth Fein is joined by John Fahrenholz, MD, Vanderbilt University Medical Center, to discuss diagnosis, emerging treatments like avapritinib, and the importance of patient advocacy and collaboration between specialists.

Comments

In Channel

Is Fixed Duration Therapy the New Standard?

2025-11-1924:46

From Diagnosis to Treatment End: Navigating Fixed-Duration Therapy for CLL

2025-10-3033:24

Functional Cure? The Promise of CLL Combination Therapy

2025-10-1724:37

Strategies to Combat Fatigue

2025-09-1929:10

Choosing Between CLL Treatments

2025-09-1018:36

Getting the Most Out of Your Doctor’s Visit

2025-08-2524:51

Treating CLL in Older Adults

2025-08-2218:58

Unraveling Cancer: Frontline Therapies for Mantle Cell Lymphoma

2025-02-2826:33

SM and Skin: A Dermatologist Explains What’s Going On

2024-10-2936:05

The Importance of Preventative Care and a Supportive Healthcare Team

2024-10-2931:41

Living Well With Indolent Systemic Mastocytosis

2024-09-3036:50

What to Eat While Being Treated for CLL

2024-09-3037:03

How Can CLL Patients Help Researchers Find a Cure?

2024-09-1739:58

Addressing Challenging Thoughts During Cancer

2024-08-2936:38

Confessions of a Clinical Trial Junkie

2024-08-2830:06

How Patients With SM "Are Their Own Quarterback"

2024-08-2631:57

00:00

Living Well With Indolent Systemic Mastocytosis

#box-pro-ellipsis-176537434302760{-webkit-line-clamp:2;}Living Well With Indolent Systemic Mastocytosis

Living Well With Indolent Systemic Mastocytosis

Patient Power

Living Well With Indolent Systemic Mastocytosis